<DOC>
	<DOCNO>NCT00198991</DOCNO>
	<brief_summary>The study evaluate efficacy tolerability intensify induction consolidation therapy . Thereafter patient receive individualised treatment stratify accord relapse risk stem cell transplantation patient high high risk relapse . Patients standard risk receive consolidation reinduction chemotherapy . In parallel minimal residual disease ( MRD ) evaluate . After six month one year decision intensification discontinuation therapy make base result MRD evaluation .</brief_summary>
	<brief_title>German Multicenter Trial Treatment Newly Diagnosed Acute Lymphoblastic Leukemia Adults ( 07/2003 )</brief_title>
	<detailed_description />
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Fludarabine</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Cytarabine</mesh_term>
	<mesh_term>Daunorubicin</mesh_term>
	<mesh_term>Idarubicin</mesh_term>
	<mesh_term>Asparaginase</mesh_term>
	<mesh_term>6-Mercaptopurine</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<mesh_term>Cladribine</mesh_term>
	<mesh_term>Vincristine</mesh_term>
	<mesh_term>Vindesine</mesh_term>
	<mesh_term>Thioguanine</mesh_term>
	<criteria>Acute lymphoblastic leukemia ( proB , common , preB , early T , thymic T , mature T ) Age 1565 yr ( *5565 year biologically young accord general condition ) Written informed consent Severe comorbidity leukemia associate complication Late relapse pediatric ALL ALL second malignancy Cytostatic pretreatment Pregnancy Severe psychiatric illness circumstance may compromise cooperation patient Participation clinical trial interfere study therapy</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2008</verification_date>
	<keyword>ALL</keyword>
	<keyword>Treatment</keyword>
	<keyword>de novo</keyword>
	<keyword>Minimal residual disease</keyword>
	<keyword>Adult</keyword>
</DOC>